Advertisement
Screener

Johnson & Johnson (JNJ) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

JOHNSON & JOHNSON Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • JOHNSON & JOHNSON return tang equity for the quarter ending 2026-06-28 was 110.14%, a 12.15% decline year-over-year.
  • JOHNSON & JOHNSON return tang equity for the quarter ending 2026-03-29 was 138.08%, a 35.24% increase year-over-year.
  • JOHNSON & JOHNSON return tang equity for the quarter ending 2025-12-28 was 174.27%, a 85.95% increase year-over-year.
  • JOHNSON & JOHNSON return tang equity for the quarter ending 2025-09-28 was 132.57%, a 2.06% increase year-over-year.
  • JOHNSON & JOHNSON return tang equity for fiscal 2025 was 174.27%, a 85.95% increase from fiscal 2024.
  • JOHNSON & JOHNSON return tang equity for fiscal 2024 was 93.72%, a 43.25% decline from fiscal 2023.
  • JOHNSON & JOHNSON return tang equity for fiscal 2023 was 165.14%, a 170.99% increase from fiscal 2023.
  • JOHNSON & JOHNSON return tang equity for fiscal 2023 was 60.94%, a 7.28% decline from fiscal 2022.
Available history
2011-01-02 to 2026-06-28
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-28110.14%$21.04B$19.1B
2026-03-29138.08%$21.04B$15.24B
2025-12-28174.27%$26.8B$15.38B
2025-09-28132.57%$25.12B$18.95B
2025-06-29125.37%$22.66B$18.08B
2025-03-30102.11%$21.81B$21.36B
2024-12-2993.72%$14.07B$15.01B
2024-09-29129.89%$14.68B$11.31B
2024-06-30285.33%$38.02B$13.32B
2024-03-31186.07%$38.48B$20.68B
2023-12-31165.14%$35.15B$21.29B
2023-10-01144.27%$34.62B$24B
2023-07-0290.41%$13.05B$14.44B
2023-04-02145.14%$12.72B$8.77B
2023-01-0160.94%$17.94B$29.44B
2022-10-0274.27%$19.16B$25.79B
2022-07-0368.99%$18.37B$26.62B
2022-04-0384.08%$19.83B$23.59B
2022-01-0265.73%$20.88B$31.77B
2021-10-03100.18%$17.88B$17.85B
2021-07-04111.60%$17.77B$15.92B
2021-04-04122.92%$15.12B$12.3B
2021-01-03187.65%$14.71B$7.84B
2020-09-2797.22%$16.99B$17.47B
2020-06-2892.85%$15.19B$16.35B
2020-03-29112.95%$17.17B$15.2B
2019-12-29106.00%$15.12B$14.26B
2019-09-29102.89%$14.15B$13.75B
2019-06-30102.96%$16.33B$15.86B
2019-03-3176.45%$14.68B$19.2B
2018-12-3076.07%$15.3B$20.11B
2018-09-306.24%$1.54B$24.7B
2018-07-016.18%$1.37B$22.19B
2018-04-015.79%$1.25B$21.52B
2017-12-317.66%$1.3B$16.97B
2017-10-0151.07%$15.83B$30.99B
2017-07-0256.33%$16.34B$29B
2017-04-0247.12%$16.51B$35.03B
2017-01-0144.36%$16.54B$37.28B
2016-10-0240.69%$15.94B$39.17B
2016-07-0337.67%$15.03B$39.89B
2016-04-0338.66%$15.55B$40.22B
2016-01-0339.43%$15.41B$39.08B
2015-09-2736.79%$14.72B$40B
2015-06-2841.05%$16.11B$39.24B
2015-03-2943.94%$15.92B$36.22B
2014-12-2843.17%$16.32B$37.82B
2014-09-2837.48%$17.32B$46.21B
2014-06-2932.86%$15.55B$47.34B
2014-03-3033.00%$15.06B$45.64B
2013-12-2932.56%$13.83B$42.48B
2013-09-2934.06%$12.88B$37.81B
2013-06-3033.00%$12.87B$38.98B
2013-03-3128.90%$10.44B$36.12B
2012-12-3032.06%$10.85B$33.85B
2012-09-3025.38%$8.5B$33.51B
2012-07-0129.06%$8.74B$30.07B

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-28174.27%$26.8B$15.38B
2024-12-2993.72%$14.07B$15.01B
2023-12-31165.14%$35.15B$21.29B
2023-01-0160.94%$17.94B$29.44B
2022-01-0265.73%$20.88B$31.77B
2021-01-03187.65%$14.71B$7.84B
2019-12-29106.00%$15.12B$14.26B
2018-12-3076.07%$15.3B$20.11B
2017-12-317.66%$1.3B$16.97B
2017-01-0144.36%$16.54B$37.28B
2016-01-0339.43%$15.41B$39.08B
2014-12-2843.17%$16.32B$37.82B
2013-12-2932.56%$13.83B$42.48B
2012-12-3032.06%$10.85B$33.85B
2012-01-0129.26%$9.67B$33.06B
2011-01-0239.93%$13.33B$33.39B

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ELI LILLY & Co (LLY)United States$1,113.804B42.28
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38